Skip to main content

Table 3 Comparison of t–AUC between Nomogram and AJCC Staging system

From: Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)

  t–AUC (Nomogram) t–AUC (AJCC Stage) P–value
6–month 0.766 0.546 < 0.001
12–month 0.715 0.554 < 0.001
18–month 0.703 0.557 < 0.001
  1. Abbreviations: AUC Area under the curve, AJCC American Joint Committee on Cancer